Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | 5252917 | None | drug-path |
| Gap junction | R-HSA-190861 | map04540 | 5252917 | None | drug-path |
| Gap junction | R-HSA-190861 | map04540 | Y-27632 | 5353788 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | 5248896 | None | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | 5248896 | None | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | 5248896 | None | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | 5248896 | None | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | 5248896 | None | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | 5248896 | None | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | 5248896 | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 5224221 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 5224221 | None | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | 5224221 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | 5224221 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 5224221 | None | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | 5224221 | None | drug-path |
| Gap junction | R-HSA-190861 | map04540 | 5224221 | None | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | 5224221 | None | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | carbamazepine | 2554 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | carbamazepine | 2554 | drug-path |